Phillip A. Barker

Phillip A. Barker

Auto-generated profile, based on publicly available information

Phillip A. Barker

Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2002 in Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
ABAsha L. Bhakar
Asha L. Bhakar
LTLaura-Lee Tannis
Laura-Lee Tannis
CZChristine Zeindler
Christine Zeindler
MRMaria Pia Russo
Maria Pia Russo
CJChristian Jobin
Christian Jobin
PBPhilip A. Barker
Philip A. Barker
The function of nuclear factor (NF)-κB within the developing and mature CNS is controversial. We have generated transgenic mice to reveal NF-κB transcriptional activity in vivo. As expected, constitutive NF-κB activity was observed within immune organs, and tumor necrosis factor-inducible NF-κB activity was present in mesenchymal cells. Intriguingly, NF-κB activity was also prominent in the CNS throughout development, especially within neocortex, olfactory bulbs, amygdala, and hippocampus. NF-κB in the CNS was restricted to neurons and blocked by overexpression of dominant-negative NF-κB-inducible kinase or the IκBαM super repressor. Blocking endogenous neuronal NF-κB activity in cortical neurons using recombinant adenovirus induced neuronal death, whereas induction of NF-κB activity increased levels of anti-apoptotic proteins and was strongly neuroprotective. Together, these data demonstrate a physiological role for NF-κB in maintaining survival of central neurons.

1 May 2004 in Neuron
Verified
Journal Article
Closed access
PBPhilip A Barker
Philip A Barker

10 December 2003 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
ABAsha L. Bhakar
Asha L. Bhakar
JHJenny L. Howell
Jenny L. Howell
CPChristine E. Paul
Christine E. Paul
ASAmir H. Salehi
Amir H. Salehi
EBEsther Barbara Elisabeth Becker
Esther Barbara Elisabeth Becker
PBPhilip A. Barker
Philip A. Barker
The p75 neurotrophin receptor (p75NTR), a member of the tumor necrosis factor receptor superfamily, facilitates apoptosis during development and after injury to the CNS. The signaling cascades activated by p75NTR that result in apoptosis remain poorly understood. In this study, we show that overexpression of p75NTR in primary cortical neurons, in pheochromocytoma cell line (PC12) cells, and in glioma cells results in activation of Jun kinase (JNK), accumulation of cytochromecwithin the cytosol, and activation of caspases 9, 6, and 3. To link p75NTR-dependent JNK activation to mitochondrial cytochromecrelease, regulation of BH3-domain-only family members was examined. Transcription of BH3-domain-only family members was not induced by p75NTR, but p75NTR-dependent JNK activation resulted in phosphorylation and oligomerization of the BH3-domain-only family member Bad. Loss of function experiments using Bad dominant negatives or RNA interference demonstrated a requirement for Bad in p75NTR-induced apoptosis. Together, these studies provide the first data linking apoptosis induced by p75NTR to the phosphorylation of BH3-domain-only family members.

2 September 2015 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
JVJorge L. Cueva Vargas
Jorge L. Cueva Vargas
IOIngrid K. Osswald
Ingrid K. Osswald
NUNicolas Unsain
Nicolas Unsain
MAMark R. Aurousseau
Mark R. Aurousseau
PBPhilip A. Barker
Philip A. Barker
APAdriana Di Polo
Adriana Di Polo
Loss of vision in glaucoma results from the selective death of retinal ganglion cells (RGCs). Tumor necrosis factor α (TNFα) signaling has been linked to RGC damage, however, the mechanism by which TNFα promotes neuronal death remains poorly defined. Using anin vivorat glaucoma model, we show that TNFα is upregulated by Müller cells and microglia/macrophages soon after induction of ocular hypertension. Administration of XPro1595, a selective inhibitor of soluble TNFα, effectively protects RGC soma and axons. Using cobalt permeability assays, we further demonstrate that endogenous soluble TNFα triggers the upregulation of Ca2+-permeable AMPA receptor (CP-AMPAR) expression in RGCs of glaucomatous eyes. CP-AMPAR activation is not caused by defects in GluA2 subunit mRNA editing, but rather reflects selective downregulation of GluA2 in neurons exposed to elevated eye pressure. Intraocular administration of selective CP-AMPAR blockers promotes robust RGC survival supporting a critical role for non-NMDA glutamate receptors in neuronal death. Our study identifies glia-derived soluble TNFα as a major inducer of RGC death through activation of CP-AMPARs, thereby establishing a novel link between neuroinflammation and cell loss in glaucoma.SIGNIFICANCE STATEMENTTumor necrosis factor α (TNFα) has been implicated in retinal ganglion cell (RGC) death, but how TNFα exerts this effect is poorly understood. We report that ocular hypertension, a major risk factor in glaucoma, upregulates TNFα production by Müller cells and microglia. Inhibition of soluble TNFα using a dominant-negative strategy effectively promotes RGC survival. We find that TNFα stimulates the expression of calcium-permeable AMPA receptors (CP-AMPAR) in RGCs, a response that does not depend on abnormal GluA2 mRNA editing but on selective downregulation of the GluA2 subunit by these neurons. Consistent with this, CP-AMPAR blockers promote robust RGC survival supporting a critical role for non-NMDA glutamate receptors in glaucomatous damage. This study identifies a novel mechanism by which glia-derived soluble TNFα modulates neuronal death in glaucoma.

1 February 2009 in Nature Neuroscience
Verified
Journal Article
Closed access
PBPhilip A Barker
Philip A Barker

1 October 2005 in EMBO Reports
Verified
Journal Article
Open access
PDF file
JMJoe P S Makkerh
Joe P S Makkerh
CCClaire Ceni
Claire Ceni
DADaniel Auld
Daniel Auld
FVFrançois Vaillancourt
François Vaillancourt
GDGenevieve Dorval
Genevieve Dorval
PBPhilip A Barker
Philip A Barker
Target‐derived neurotrophins regulate neuronal survival and growth by interacting with cell‐surface tyrosine kinase receptors. The p75 neurotrophin receptor (p75NTR) is coexpressed with Trk receptors in long‐range projection neurons, in which it facilitates neurotrophin binding to Trk and enhances Trk activity. Here, we show that TrkA and TrkB receptors undergo robust ligand‐dependent ubiquitination that is dependent on activation of the endogenous Trk activity of the receptors. Coexpression of p75NTR attenuated ubiquitination of TrkA and TrkB and delayed nerve growth factor‐induced TrkA receptor internalization and receptor degradation. These results indicate that p75NTR may prolong cell‐surface Trk‐dependent signalling events by negatively regulating receptor ubiquitination.